Literature DB >> 10919498

Th1/Th2 lymphocyte polarization in asthma.

G Mazzarella1, A Bianco, E Catena, R De Palma, G F Abbate.   

Abstract

Asthma is a complex inflammatory disease of the lung characterized by variable airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Inflammation in asthma consists of airway infiltration by mast cells, lymphocytes, and eosinophils. There is accumulating evidence that CD4+ lymphocytes with a Th2-cytokine pattern play a pivotal role in the pathogenesis of asthma. These cells orchestrate the recruitment and activation of the primary effector cells of the allergic response (mast cells and eosinophils), through the release of cytokines such as IL-4, IL-5, and IL-13. Allergic inflammation is also implicated in airway epithelium changes, although the mechanisms by which inflammatory cells and, in particular, T cells interact with the epithelium are not completely clarified. This paper explores the role of T cells in the allergic inflammation of asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919498     DOI: 10.1034/j.1398-9995.2000.00511.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  39 in total

1.  T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

Authors:  G Mazzarella; A Bianco; F Perna; D D'Auria; E Grella; E Moscariello; A Sanduzzi
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 2.  TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.

Authors:  Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

Review 4.  Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity.

Authors:  Tomohide Hori; Kagemasa Kuribayashi; Kanako Saito; Linan Wang; Mie Torii; Shinji Uemoto; Taku Iida; Shintaro Yagi; Takuma Kato
Journal:  World J Transplant       Date:  2015-03-24

5.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

6.  Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model.

Authors:  Chunxia Li; Jun Dai; Guanjun Dong; Qun Ma; Zhihua Li; Hui Zhang; Fenglian Yan; Junfeng Zhang; Bo Wang; Hui Shi; Yuzhen Zhu; Xiaoying Yao; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

7.  8-Oxoguanine-DNA glycosylase 1 deficiency modifies allergic airway inflammation by regulating STAT6 and IL-4 in cells and in mice.

Authors:  Guoping Li; Kefei Yuan; Chunguang Yan; John Fox; Madeleine Gaid; Wayne Breitwieser; Arvind K Bansal; Huawei Zeng; Hongwei Gao; Min Wu
Journal:  Free Radic Biol Med       Date:  2011-11-03       Impact factor: 7.376

Review 8.  The identification of potentially pathogenic and therapeutic epitopes from common human allergens.

Authors:  Véronique Schulten; Carla Oseroff; Rafeul Alam; David Broide; Pandurangan Vijayanand; Bjoern Peters; Alessandro Sette
Journal:  Ann Allergy Asthma Immunol       Date:  2012-11-15       Impact factor: 6.347

9.  Soluble CD86 protein in serum samples of patients with asthma.

Authors:  H-Z Shi; Z-F Xie; J-M Deng; Y-Q Chen; C-Q Xiao
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

10.  Effective antigen presentation to helper T cells by human eosinophils.

Authors:  Ruhaifah K Farhan; Mark A Vickers; Amir M Ghaemmaghami; Andrew M Hall; Robert N Barker; Garry M Walsh
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.